VANGUARD GROUP INC - 31 Dec 2025 SCHEDULE 13G Report for Tango Therapeutics Inc Common Stock (TNGX)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Tango Therapeutics Inc Common Stock
Symbol: TNGX
Shares outstanding: 134,750,040 shares
Disclosed Ownership: 6,750,977 shares
Ownership: 5%
Form type: SCHEDULE 13G
Filing time: 30 Jan 2026, 14:44:14 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	5%	6,750,977	0	742,606	Ashley Grim	Head of Global Fund Administration